Literature DB >> 24713227

Prevalence of antibodies against Treponema pallidum among HIV-positive patients in a tertiary care hospital in Mexico.

José Antonio Mata-Marín1, Juan Joel Sandoval-Sánchez2, Gloria Huerta-García3, Carla Ileana Arroyo-Anduiza4, Enrique Alcalá-Martínez2, Luis Alberto Mata-Marín5, Jorge Luis Sandoval-Ramirez6, Jesús Gaytán-Martínez6.   

Abstract

Our objective was to determine the seroprevalence of syphilis among HIV-infected patients in a tertiary care hospital in Mexico City. A cross-sectional study was developed, and 318 HIV-positive patients were evaluated from January to February 2013 at Hospital de Infectología, National Medical Center 'La Raza' (a tertiary care hospital specialising in infectious diseases in Mexico City). Laboratory data were screened for the detection of antibodies against Treponema pallidum. Patients completed a questionnaire relating to socio-demographic data and factors associated with syphilis. Of the 318 patients, 83% were men. The mean age ± SD was 36 ± 11 years; 52% were men who have sex with men and 47% had undertaken higher education. The overall seroprevalence of syphilis among these patients was 25% (95% confidence interval 21%, 30%). Men who have sex with men had a significantly higher seroprevalence (30% vs. 15%, p = 0.009). We conclude that, in Mexico, there is a high seroprevalence of syphilis antibodies in HIV-infected patients and that men who have sex with men are the group most affected.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  AIDS; HIV; Treponema pallidum; clinical features; epidemiology; prevalence; sexually transmitted infection; socio-demographic; syphilis

Mesh:

Substances:

Year:  2014        PMID: 24713227     DOI: 10.1177/0956462414530888

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  1 in total

1.  Consequences of HIV/Syphilis Co-Infection on HIV Viral Load and Immune Response to Antiretroviral Therapy.

Authors:  Lina Fan; Aiping Yu; Defa Zhang; Ziyu Wang; Ping Ma
Journal:  Infect Drug Resist       Date:  2021-07-24       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.